Progress on gene therapy, cell therapy, and pharmacological strategies toward the treatment of oculopharyngeal muscular dystrophy. Hum. Gene Ther. 26, 286–292 (2015). 21. Trollet, C. et al. Molecular and phenotypic characterization of a mouse model of oculopharyngeal muscular dystrophy reveals ...
analoga such as 3 -azido-2 ,3 -dideoxythymine (AZT)—or on the other hand, the telomerase RNA (hTR) component—via antisense oligonucleotides or the more specific telomerase template antagonists such as the 13-mer oligonucleotide N3 -P5 -thio-phosphoramidate (GRN163L, imetelstat) [55,57]....
Progress note tracking and alerts THE AFTER PATIENT EXPERIENCE (billing automation) Complete billing software and clearing house integration like you’ve never seen before Automatic claim scrubbing Flexibility for biller to review/edit/update claims prior to payer submission ...